Contrary to initial expectations, no significant associations were observed between anti-α-fodrin antibodies and disease severity, organ involvement, or anti-Ro/anti-Ro52 antibodies in SLE patients. This evidence concerns the gene TRIM21 and systemic lupus erythematosus.